Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and... see more

TSX:WEED - Post Discussion

Canopy Growth Corp > HHS Recommends Cannabis (Article Clips + Letter to DEA)
View:
Post by quinlash on Mar 25, 2024 8:04pm

HHS Recommends Cannabis (Article Clips + Letter to DEA)

Not too sure how many folks actually took the time to research the HHS Letter of Recommendation to Reschedule Cannabis however, due to mis-statements made on this forum today I am opting to put out the facts in case there are a few out there trading in potentially the wrong direction.

Below are CLIPS from the article I link to at the bottom of the post.  For the full article use the link to see it all.

Do some folks a favor, if you are on mutiple forums then copy and paste this post and share it or simply share a link - Cannabis Bulls thank you.


(Article) HHS Releases Unredacted Report Recommending Cannabis Rescheduling

"On August 29, 2023, the U.S. Department of Health and Human Services (HHS) submitted an analysis to the Drug Enforcement Agency (DEA) recommending that cannabis be rescheduled as a Schedule III controlled substance. HHS finally made this report public in its unredacted form last Friday"

"... enough data for HHS to conclude, in the totality, that medicinal use of cannabis has scientific support. HHS also considered the use of cannabis in the treatment of anxiety, epilepsy, PTSD, and inflammatory bowel disease ... "


Link to full Article
https://www.shipmangoodwin.com/insights/hhs-releases-unredacted-report-recommending-cannabis-rescheduling.html


Clip from HHS Letter of Recommendation to Reschedule To Schedule III (Page 25)

In Part 1 of the CAMU test, OASH identified at least 15 medical conditions where there is widespread current experience with medical use of the substance in the United States by licensed HCPs operating in accordance with implemented state authorized programs, where the medical use is recognized by entities that regulate the practice of medicine.
 
These conditions include amyotrophic lateral sclerosis (ALS), autism, cachexia, cancer, chronic pain, Crohn’s disease, epilepsy or condition causing seizures, glaucoma, HIV/AIDs, multiple sclerosis, Parkinson’s disease, persistent/severe muscle spasm, persistent/severe nausea, PTSD, and spasticity. FDA conducted Part 2 of the analysis for the medical conditions identified by OASH that were likely to have the most robust evidence available for review; because the analysis concluded that the Part 2 test has been met for at least one of the conditions identified in Part 1, there was no need to analyze all of them

Link to:
BASIS FOR THE RECOMMENDATION TO RESCHEDULE MARIJUANA IN TO SCHEDULE III
OF THE CONTROLLED SUBSTANCES ACT


https://www.dropbox.com/scl/fi/pw3rfs9gm6lg80ij9tja6/2023-01171-Supplemental-Release-1.pdf?rlkey=v5atj0tcnhxhnszyyzcwdcvvt&dl=0
Comment by quinlash on Mar 26, 2024 1:10pm
Nonsense abiut cannabis being a gateway drug is from the Regan era, long predating where some folks on this forum were even born.  The HHS letter to the DEA is provided in my earlier post where the HHS acknowledged cannabis as having  both medical benefit and low chance of addiction. Alcohol is freely available and has far more concerns associated with it vs cannabis IMHO Get educated  ...more  
Comment by quinlash on Mar 26, 2024 7:42pm
The HHS letter is linked here, it's well over 100 pages of content recommending the rescheduling of cannabis to Schedule III. Personally I think cannabis is less harmful than alcohol and should be made legal and I am also looking at the fact that 44 out of 50 US states already legalized cannabis, either for medical / rec or both.  These facts make me believe we will indeed see the US ...more  
Comment by quinlash on Apr 01, 2024 5:52pm
The US HHS letter cities the benefits and why the DEA should reschedule cannabis.
Comment by quinlash on Apr 01, 2024 10:01pm
HHS already pointed out apx 44 reasons (including medical) reasons why cannabis needs to be legalized.  Many of the concerns being heard these days are faint echos of the Regan Era war on drugs campaign
Comment by quinlash on Apr 03, 2024 9:01pm
HHS is promoting it for both medical and recreational.  I seriously doubt many even realize this yet (or at least read up on it)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities